Charles Ouazana-Vedrines (Charles Ouazana Vedrines)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Bipolar Disorder

Ejection Fraction

Top Venues

Molecular psychiatry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Guillaume Airagnes, Marina Sánchez-Rico, Amélia Deguilhem, Carlos Blanco, Mark Olfson, Charles Ouazana-Vedrines, Cédric Lemogne, Frederic Limosin, Nicolas Hoertel
Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study. Molecular psychiatry (2024)
Nicolas Hoertel, Katayoun Rezaei, Marina Sánchez-Rico, Alfonso Delgado-Álvarez, Kornhuber Johannes, Erich Gulbins, Mark Olfson, Charles Ouazana-Vedrines, Alexander Carpinteiro, Céline Cougoule, Katrin Anne Becker, Jesús M Alvarado, Frédéric Limosin, null On Behalf Of The Ap-Hp/Université Paris Cité/Inserm Covid-Research Collaboration Ap-Hp Covid Cdr Initiative And Entrepôt de Données de Santé Ap-Hp Consortium
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Guy-Marino Hinnouho, Olivier Robineau, Emmanuel Wiernik, Fabrice Carrat, Gianluca Severi, Mathilde Touvier, Clément Gouraud, Charles Ouazana-Vedrines, Victor Pitron, Brigitte Ranque, Baptiste Pignon, Nicolas Hoertel, Sofiane Kab, Marcel Goldberg, Marie Zins, Cédric Lemogne
Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study. Molecular psychiatry (2023)